title: Part II. Introduction to the beta-lactam antibiotics.
authors.affiliation: Infectious Diseases Section, PO Box 26901, WP 1160, Oklahoma City, OK 73190, USA.
authors.forename: Travis W
authors.initials: TW
authors.lastname: Cooper
authors.forename: Winter J
authors.initials: WJ
authors.lastname: Gibbs
authors.forename: Michael S
authors.initials: MS
authors.lastname: Bronze
authors.forename: Ronald A
authors.initials: RA
authors.lastname: Greenfield
mesh_terms: D000284:Administration, Oral; D000707:Anaphylaxis / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D015780:Carbapenems / Q000009:adverse effects / Q000494:pharmacology; D002511:Cephalosporins / Q000009:adverse effects / Q000494:pharmacology; D003429:Cross Reactions; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D006801:Humans; D007275:Injections, Intravenous; D008826:Microbial Sensitivity Tests; D008997:Monobactams / Q000009:adverse effects / Q000494:pharmacology; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012882:Skin Tests; D013997:Time Factors; D018440:beta-Lactam Resistance; D047090:beta-Lactams / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002511:Cephalosporins; D008997:Monobactams; D010406:Penicillins; D047090:beta-Lactams